Celyad Oncology Earning Date (CYAD)

USA |NASDAQ |USD |ADR

CYAD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Sep 30, 2021 - $-0.55 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Sep 30, 2021 - $0.00 $0.00

CYAD Earnings Date & History Chart

CYAD Earnings & Revenue Forecast

CYAD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast

CYAD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend

CYAD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast

CYAD Earnings Date & Revenue History

CYAD Earnings History

|
Show More
Show More

CYAD Revenue History

|
Show More
Show More

Celyad Oncology Next Earnings Date & Report

CYAD Sep 2021 (FQ) Earnings Date & Report Preview

Celyad Oncology Previous Earnings Dates & Reports

CYAD Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Celyad Oncology's previous earnings date was Sep 30, 2021 for its fiscal quarter ended Jun 30, 2021.

CYAD's earnings per share (EPS) was $-0.55.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 12.04%.

Revenues were $0.00.

The company reported a net income of $-6.15M.

CYAD ended the quarter with $3.08M in total debt, a decrease of -9.36% compared to the previous quarter, and a decrease of -16.82% compared to the same quarter a year before.

CYAD Previous Earnings Date & Report Recap: Dec 2020 (FY)

Celyad Oncology's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.

CYAD's earnings per share (EPS) was $-1.38.

Revenues were $5.00K, down by -16.67% from previous year's revenue.

The company reported a net income of $-17.20M.

Celyad Oncology reported a free cash flow of $-27.98M for its fiscal year, compared to $-28.82M a year ago.

The company ended the fiscal year with $3.64M in total debt, a decrease of -16.62% compared to the previous year.